HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joseph F. Sabik Thomas W. Rice Thomas J. Kirby Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sabik, J. F. Articles by Adelstein, D. J. Search for Related Content PubMed PubMed Citation Articles by Sabik, J. F. Articles by Adelstein, D. J. Related Collections Related Article

Ann Thorac Surg 1995;60:896-901
© 1995 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Superficial Esophageal Carcinoma

Departments of Thoracic and Cardiovascular Surgery, Anatomic Pathology, Radiation Oncology, Biostatistics and Epidemiology, and Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio

Background. The detection of superficial esophageal carcinomas by surveillance endoscopy and the downstaging of advanced carcinomas to superficial carcinomas by induction therapy have increased the number of patients with these carcinomas undergoing resection. The natural history of these carcinomas is not well defined.

Methods. To evaluate the results of surgical resection and identify predictors of improved survival, a retrospective review of (1) patients with superficial esophageal carcinoma at presentation (SECP) and (2) patients with advanced carcinomas that were downstaged to no residual carcinoma or superficial esophageal carcinoma after induction therapy (SECD) was conducted.

Results. There were 54 patients with SECP (19 Tis and 35 T1). Survival was significantly better for patients with Tis carcinomas (85.3% at 5 years) and patients with intramucosal T1 carcinomas (79.4%) than for patients with submucosal T1 carcinomas (16.3%) (p = 0.007 and p = 0.045, respectively). Survival at 5 years for the 49 patients without regional lymph node metastases (N0) was 65.2%, whereas none of the 5 patients with regional lymph node metastases (N1) have survived more than 3 years (p = 0.054), and 3 died of recurrent disease. There were 21 patients with SECD (13 T0, 2 Tis, and 6 T1). Survival at 4 years was 58.2%. In this group, survival was not related to depth of tumor invasion (p = 0.76) or regional lymph node status (p = 0.68).

Conclusions. We conclude that (1) patients with Tis and intramucosal T1 SECP have a significantly better survival than those with submucosal T1 SECP, (2) patients with N0 SECP have a significantly better survival than those with N1 SECP, and (3) survival of patients with SECD is not related to depth of tumor invasion or regional lymph node status.

Related Article

Discussion
Ann. Thorac. Surg. 1995 60: 902. [Extract] [Full Text]

This article has been cited by other articles:

				M. S. Smith and C. J. Lightdale Review: Barrett's esophagus and the increasing role of endoluminal therapy Therapeutic Advances in Gastroenterology, September 1, 2008; 1(2): 121 - 142. [Abstract] [PDF]

				S. Rampado, P. Bocus, G. Battaglia, A. Ruol, G. Portale, and E. Ancona Endoscopic Ultrasound: Accuracy in Staging Superficial Carcinomas of the Esophagus Ann. Thorac. Surg., January 1, 2008; 85(1): 251 - 256. [Abstract] [Full Text] [PDF]

				M S Dar, J R Goldblum, T W Rice, and G W Falk Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut, April 1, 2003; 52(4): 486 - 489. [Abstract] [Full Text] [PDF]

				J. A. Hagen and T. R. DeMeester Esophageal adenocarcinoma Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432. [Full Text] [PDF]

				J. J. Nigro, J. A. Hagen, T. R. DeMeester, S. R. DeMeester, J. H. Peters, S. Oberg, J. Theisen, M. Kiyabu, P. F. Crookes, and C. G. Bremner PREVALENCE AND LOCATION OF NODAL METASTASES IN DISTAL ESOPHAGEAL ADENOCARCINOMA CONFINED TO THE WALL: IMPLICATIONS FOR THERAPY J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 16 - 25. [Abstract] [Full Text] [PDF]

				T. W. Rice COMMENTARY: ESOPHAGEAL CARCINOMA CONFINED TO THE WALL—THE NEED FOR IMMEDIATE DEFINITIVE THERAPY J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 26 - 27. [Full Text] [PDF]

				T. W. Rice, G. Zuccaro Jr, D. J. Adelstein, L. A. Rybicki, E. H. Blackstone, and J. R. Goldblum Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status Ann. Thorac. Surg., March 1, 1998; 65(3): 787 - 792. [Abstract] [Full Text] [PDF]

				F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848. [Abstract] [Full Text]

				W. A. Killinger Jr., T. W. Rice, D. J. Adelstein, S. V. Medendorp, G. Zuccaro, T. J. Kirby, and J. R. Goldblum STAGE II ESOPHAGEAL CARCINOMA: THE SIGNIFICANCE OF T AND N J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 935 - 940. [Abstract] [Full Text]